122 related articles for article (PubMed ID: 31474002)
1. Matrix Assisted Laser Desorption/Ionization Mass Spectrometry Imaging (MALDI MSI) for Monitoring of Drug Response in Primary Cancer Spheroids.
Mittal P; Price ZK; Lokman NA; Ricciardelli C; Oehler MK; Klingler-Hoffmann M; Hoffmann P
Proteomics; 2019 Nov; 19(21-22):e1900146. PubMed ID: 31474002
[TBL] [Abstract][Full Text] [Related]
2. Quantitative Assessment of Anti-Cancer Drug Efficacy From Coregistered Mass Spectrometry and Fluorescence Microscopy Images of Multicellular Tumor Spheroids.
Michálek J; Štěpka K; Kozubek M; Navrátilová J; Pavlatovská B; Machálková M; Preisler J; Pruška A
Microsc Microanal; 2019 Dec; 25(6):1311-1322. PubMed ID: 31571549
[TBL] [Abstract][Full Text] [Related]
3. How Suitable is Matrix-Assisted Laser Desorption/Ionization-Time-of-Flight for Metabolite Imaging from Clinical Formalin-Fixed and Paraffin-Embedded Tissue Samples in Comparison to Matrix-Assisted Laser Desorption/Ionization-Fourier Transform Ion Cyclotron Resonance Mass Spectrometry?
Buck A; Balluff B; Voss A; Langer R; Zitzelsberger H; Aichler M; Walch A
Anal Chem; 2016 May; 88(10):5281-9. PubMed ID: 27065343
[TBL] [Abstract][Full Text] [Related]
4. Multicellular detachment generates metastatic spheroids during intra-abdominal dissemination in epithelial ovarian cancer.
Al Habyan S; Kalos C; Szymborski J; McCaffrey L
Oncogene; 2018 Sep; 37(37):5127-5135. PubMed ID: 29789717
[TBL] [Abstract][Full Text] [Related]
5. Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging.
Smith A; Galli M; Piga I; Denti V; Stella M; Chinello C; Fusco N; Leni D; Manzoni M; Roversi G; Garancini M; Pincelli AI; Cimino V; Capitoli G; Magni F; Pagni F
J Proteomics; 2019 Jan; 191():114-123. PubMed ID: 29581064
[TBL] [Abstract][Full Text] [Related]
6. Mass Spectrometry Analyses of Multicellular Tumor Spheroids.
Acland M; Mittal P; Lokman NA; Klingler-Hoffmann M; Oehler MK; Hoffmann P
Proteomics Clin Appl; 2018 May; 12(3):e1700124. PubMed ID: 29227035
[TBL] [Abstract][Full Text] [Related]
7. Strategies for managing multi-patient 3D mass spectrometry imaging data.
Vos DRN; Jansen I; Lucas M; Paine MRL; de Boer OJ; Meijer SL; Savci-Heijink CD; Marquering HA; de Bruin DM; Heeren RMA; Ellis SR; Balluff B
J Proteomics; 2019 Feb; 193():184-191. PubMed ID: 30343012
[TBL] [Abstract][Full Text] [Related]
8. High-resolution MALDI-FT-ICR MS imaging for the analysis of metabolites from formalin-fixed, paraffin-embedded clinical tissue samples.
Buck A; Ly A; Balluff B; Sun N; Gorzolka K; Feuchtinger A; Janssen KP; Kuppen PJ; van de Velde CJ; Weirich G; Erlmeier F; Langer R; Aubele M; Zitzelsberger H; Aichler M; Walch A
J Pathol; 2015 Sep; 237(1):123-32. PubMed ID: 25965788
[TBL] [Abstract][Full Text] [Related]
9. Mass spectrometry imaging revealed alterations of lipid metabolites in multicellular tumor spheroids in response to hydroxychloroquine.
Chen Y; Wang T; Xie P; Song Y; Wang J; Cai Z
Anal Chim Acta; 2021 Nov; 1184():339011. PubMed ID: 34625248
[TBL] [Abstract][Full Text] [Related]
10. MS imaging of multicellular tumor spheroids and organoids as an emerging tool for personalized medicine and drug discovery.
Wang Y; Hummon AB
J Biol Chem; 2021 Oct; 297(4):101139. PubMed ID: 34461098
[TBL] [Abstract][Full Text] [Related]
11. Mass Spectrometry Imaging Combined with Metabolomics Revealing the Proliferative Effect of Environmental Pollutants on Multicellular Tumor Spheroids.
Xie P; Liang X; Song Y; Cai Z
Anal Chem; 2020 Aug; 92(16):11341-11348. PubMed ID: 32668148
[TBL] [Abstract][Full Text] [Related]
12. Anticancer Drug Affects Metabolomic Profiles in Multicellular Spheroids: Studies Using Mass Spectrometry Imaging Combined with Machine Learning.
Tian X; Zhang G; Zou Z; Yang Z
Anal Chem; 2019 May; 91(9):5802-5809. PubMed ID: 30951294
[TBL] [Abstract][Full Text] [Related]
13. Mesothelial cells interact with tumor cells for the formation of ovarian cancer multicellular spheroids in peritoneal effusions.
Matte I; Legault CM; Garde-Granger P; Laplante C; Bessette P; Rancourt C; Piché A
Clin Exp Metastasis; 2016 Dec; 33(8):839-852. PubMed ID: 27612856
[TBL] [Abstract][Full Text] [Related]
14. MALDI Mass Spectrometry Imaging of Early- and Late-Stage Serous Ovarian Cancer Tissue Reveals Stage-Specific N-Glycans.
Briggs MT; Condina MR; Ho YY; Everest-Dass AV; Mittal P; Kaur G; Oehler MK; Packer NH; Hoffmann P
Proteomics; 2019 Nov; 19(21-22):e1800482. PubMed ID: 31364262
[TBL] [Abstract][Full Text] [Related]
15. Fresh Frozen Versus Formalin-Fixed Paraffin Embedded for Mass Spectrometry Imaging.
Patel E
Methods Mol Biol; 2017; 1618():7-14. PubMed ID: 28523495
[TBL] [Abstract][Full Text] [Related]
16. Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers.
Burleson KM; Casey RC; Skubitz KM; Pambuccian SE; Oegema TR; Skubitz AP
Gynecol Oncol; 2004 Apr; 93(1):170-81. PubMed ID: 15047232
[TBL] [Abstract][Full Text] [Related]
17. Oncoproteomics: Trials and tribulations.
Zhou L; Li Q; Wang J; Huang C; Nice EC
Proteomics Clin Appl; 2016 Apr; 10(4):516-31. PubMed ID: 26518147
[TBL] [Abstract][Full Text] [Related]
18. MALDI IMS and Cancer Tissue Microarrays.
Casadonte R; Longuespée R; Kriegsmann J; Kriegsmann M
Adv Cancer Res; 2017; 134():173-200. PubMed ID: 28110650
[TBL] [Abstract][Full Text] [Related]
19. Differentiating tumor heterogeneity in formalin-fixed paraffin-embedded (FFPE) prostate adenocarcinoma tissues using principal component analysis of matrix-assisted laser desorption/ionization imaging mass spectral data.
Panderi I; Yakirevich E; Papagerakis S; Noble L; Lombardo K; Pantazatos D
Rapid Commun Mass Spectrom; 2017 Jan; 31(2):160-170. PubMed ID: 27791282
[TBL] [Abstract][Full Text] [Related]
20. Modulation of AKT activity is associated with reversible dormancy in ascites-derived epithelial ovarian cancer spheroids.
Correa RJ; Peart T; Valdes YR; DiMattia GE; Shepherd TG
Carcinogenesis; 2012 Jan; 33(1):49-58. PubMed ID: 22045027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
